HLA-DR frequency in Turkish aplastic anemia patients and the impact of HLA-DR2 positivity in response rate in patients receiving immunosuppressive therapy.
Ilhan
O
O
Beksaç
M
M
Koç
H
H
Akan
H
H
Keskin
A
A
Arslan
O
O
Gürman
G
G
Ozcan
M
M
Konuk
N
N
Uysal
A
A
D000293:Adolescent; D000328:Adult; D000741:Anemia, Aplastic / Q000097:blood / Q000276:immunology* / Q000628:therapy*; D016026:Bone Marrow Transplantation / Q000276:immunology*; D002648:Child; D016001:Confidence Intervals; D005260:Female; D006684:HLA-DR Antigens / Q000097:blood* / Q000235:genetics; D015802:HLA-DR2 Antigen / Q000097:blood*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D014421:Turkey
D006684:HLA-DR Antigens; D015802:HLA-DR2 Antigen; D007166:Immunosuppressive Agents